MiR-559 targets GP73 to suppress proliferation and invasion of hepatocellular carcinoma in vitro

被引:9
作者
Zheng, Xue-Song [1 ]
Liu, Hai-Jie [2 ]
Zhang, Lian-Lian [3 ]
Li, Hui [4 ]
Wang, Chun-Jing [5 ]
Xin, Ye-Jiu [6 ]
Hao, Rui [7 ]
机构
[1] Beihua Univ, Dept Otolaryngol, Affiliated Hosp, Jilin, Jilin, Peoples R China
[2] Beihua Univ, Dept Ultrasonog, Affiliated Hosp, Jilin, Jilin, Peoples R China
[3] Beihua Univ, Dept Pharm, Affiliated Hosp, Jilin, Jilin, Peoples R China
[4] Beihua Univ, Dept Clin Lab, Affiliated Hosp, Jilin, Jilin, Peoples R China
[5] Beihua Univ, Dept Gastroenterol, Affiliated Hosp, Jilin, Jilin, Peoples R China
[6] Beihua Univ, Dept Cardiovasc Med, Affiliated Hosp, Jilin, Jilin, Peoples R China
[7] Beihua Univ, Dept Infect Dis, Affiliated Hosp, 12 Jiefangzhong Rd, Jilin, Jilin, Peoples R China
关键词
GP73; hepatocellular carcinoma; invasion; miR-559; proliferation; SERUM GP73; MICRORNAS; EXPRESSION;
D O I
10.1002/kjm2.12246
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hepatocellular carcinoma (HCC) is one of the common malignant tumors with poor overall prognosis. As a tumor suppressor, the function of miR-559 in HCC is not clear. In this study, quantitative real-time PCR was carried out to measure the expression of miR-559 in HCC cell lines. The effects of miR-559 on HCC cell proliferation, migration, and invasion were evaluated through a series of functional assays. The mechanism through which miR-559 regulates HCC cells was investigated by dual-luciferase reporter assay and functional experiments. The results revealed that miR-559 expression was low in HCC cell lines. Upregulation of miR-559 suppressed HCC cell proliferation, migration, and invasion. Dual-luciferase reporter assay confirmed Golgi membrane protein 73 (GP73) as a target gene of miR-559. Moreover, miR-559 could negatively regulate GP73 expression in HCC cells. These results demonstrated that low-level expression of miR-559 was associated with HCC, and overexpression of miR-559 could inhibit HCC cell growth and invasion via targeting GP73.
引用
收藏
页码:793 / 798
页数:6
相关论文
共 27 条
  • [1] Preliminary validation of ERBB2 expression regulated by miR-548d-3p and miR-559
    Chen, Hong
    Sun, Jian-guo
    Cao, Xue-wu
    Ma, Xiao-gan
    Xu, Jian-ping
    Luo, Fu-kang
    Chen, Zheng-tang
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 385 (04) : 596 - 600
  • [2] Update on hepatocellular carcinoma: Pathologists' review
    El Jabbour, Tony
    Lagana, Stephen M.
    Lee, Hwajeong
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (14) : 1653 - 1665
  • [3] MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1
    Ge, Xin
    Gong, Liansheng
    [J]. TUMOR BIOLOGY, 2017, 39 (03) : 1 - 8
  • [4] MicroRNAs Regulating MicroRNAs in Cancer
    Hill, Meredith
    Nham Tran
    [J]. TRENDS IN CANCER, 2018, 4 (07): : 465 - 468
  • [5] MicroRNA-362-3p attenuates motor deficit following spinal cord injury via targeting paired box gene 2
    Hu, Yaguang
    Liu, Qian
    Zhang, Min
    Yan, Yousheng
    Yu, Hongmei
    Ge, Li
    [J]. JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2019, 18 (01) : 57 - 64
  • [6] Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115, 10.3322/caac.21492]
  • [7] Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma
    Jia, Pengbo
    Wei, Guangbing
    Zhou, Cancan
    Gao, Qi
    Wu, Yunhua
    Sun, Xuejun
    Li, Xuqi
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
  • [8] Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases
    Jiang, Kai
    Shang, Shuxin
    Li, Wei
    Guo, Kun
    Qin, Xue
    Zhang, Shu
    Liu, Yinkun
    [J]. GLYCOCONJUGATE JOURNAL, 2015, 32 (09) : 657 - 664
  • [9] Knockdown of miR-299-Sp inhibits the progression of hepatocellular carcinoma by targeting SIAH1
    Jiang, Xinghua
    Shen, Xiaoxu
    [J]. BULLETIN DU CANCER, 2018, 105 (10) : 873 - 883
  • [10] MiR-520b restrains cell growth by targeting HDAC4 in lung cancer
    Jin, Ke
    Zhao, Weixin
    Xie, Xuan
    Pan, Yuejiang
    Wang, Kexi
    Zhang, Huizhong
    [J]. THORACIC CANCER, 2018, 9 (10) : 1249 - 1254